Capricor Therapeutics
CAPR
CAPR
25 hedge funds and large institutions have $6.8M invested in Capricor Therapeutics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
71% less call options, than puts
Call options by funds: $311K | Put options by funds: $1.07M
Holders
25
Holding in Top 10
–
Calls
$311K
Puts
$1.07M
Top Buyers
| 1 | +$198K | |
| 2 | +$67K | |
| 3 | +$53.8K | |
| 4 |
Goldman Sachs
New York
|
+$24.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11K |
Top Sellers
| 1 | -$388K | |
| 2 | -$222K | |
| 3 | -$215K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$92.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$69.7K |